← FDA Drug Approvals (Drugs@FDA)

VIGABATRIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA · Approved 2019-01-14

Drug application

FDA Application #

ANDA209822

Application type

Abbreviated New Drug Application (Generic)

Brand name

VIGABATRIN

Generic name

VIGABATRIN

Active ingredients

VIGABATRIN

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

TEVA PHARMS USA

Manufacturer

Actavis Pharma, Inc.

First approval

2019-01-14

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown